Short answer · Medically reviewed summary · Last updated: 2026-04-07
Hyperkalemic periodic paralysis, often abbreviated as HyperPP, is a rare genetic muscle disorder primarily characterized by episodes of muscle weakness and elevated serum potassium levels. It is also historically and clinically referred to as Gamstorp disease or adynamia episodica hereditaria, reflecting its hereditary nature and episodic clinical presentation. What are the common synonyms and historical names for Hyperkalemic periodic paralysis? In medical literature, Hyperkalemic periodic paralysis is frequently identified by several synonyms that reflect its clinical history.
Hyperkalemic periodic paralysis, often abbreviated as HyperPP, is a rare genetic muscle disorder primarily characterized by episodes of muscle weakness and elevated serum potassium levels. It is also historically and clinically referred to as Gamstorp disease or adynamia episodica hereditaria, reflecting its hereditary nature and episodic clinical presentation.
In medical literature, Hyperkalemic periodic paralysis is frequently identified by several synonyms that reflect its clinical history. The most prominent historical name is adynamia episodica hereditaria, a term coined by Dr. Ingrid Gamstorp in 1956, which is why you may also see it referred to as Gamstorp disease. Other terms you might encounter in older medical records or international literature include potassium-sensitive periodic paralysis and familial episodic adynamia. Understanding these synonyms is vital for patients when navigating historical health records or cross-referencing information from international medical databases.
The existence of multiple names for Hyperkalemic periodic paralysis stems from the evolution of clinical neurology and genetic discovery. Early researchers named the condition based on the observable symptoms (paralysis/adynamia) and the pattern of inheritance (hereditaria). As clinical understanding shifted toward the underlying electrolyte imbalance, the name Hyperkalemic periodic paralysis became the preferred clinical term because it specifically identifies the hallmark elevation of potassium (hyperkalemia) during or between attacks. This transition from symptom-based naming to pathophysiology-based naming is common in rare diseases as diagnostic science matures.
To ensure consistency in diagnosis and research, Hyperkalemic periodic paralysis is tracked using standardized coding systems. These codes help clinicians, insurers, and researchers categorize the disease accurately:
While historical terms like Gamstorp disease remain in the literature for academic context, the current medical standard is Hyperkalemic periodic paralysis. This name is preferred because it is descriptive, clinically accurate, and aligns with the genetic classification of the disease as a skeletal muscle sodium channelopathy. When communicating with specialists, such as neurologists or geneticists, using the term Hyperkalemic periodic paralysis will ensure the most precise identification of the condition and facilitate better coordination of care for the 21 members of the DiseaseMaps community currently managing this diagnosis.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.